Live Breaking News & Updates on Axenda

Stay informed with the latest breaking news from Axenda on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Axenda and stay connected to the pulse of your community

AANA posts new guidelines on weight loss drugs

"New guidelines from AANA for anesthesia care of patients using GLP-1 agonists like Ozempic and Saxenda, including fasting and additional screenings to mitigate

United-states , American , American-association-of-nurse-anesthesiology , American-association , Nurse-anesthesiology , Meta-keywords-american-association-of-nurse-anesthesiology , Uidelines , Lucagon-like-peptide-1-agonists , Zempic , Egovy , Axenda

Stopping Saxenda: Exercise may help maintain weight loss

New research suggests that people who stop taking GLP-1 drugs for weight management can still maintain their weight loss following treatment by adhering to a regular exercise regime.

United-states , Hvidovre , Hovedstaden , Denmark , Copenhagen , Køavn- , Danish , Klaus-vedfelt-getty , Mir-ali , University-of-copenhagen , Drug-administration , Hvidovre-hospital

FDA approves new weight loss drug

FDA approves Eli Lilly's Zepbound, a weekly injection for chronic weight management, for obese or overweight adults with at least one weight-related condition.

Novo-nordisk-ozempic , Novo-nordisk-saxenda , Eli-lilly-zepbound , Eli-lilly-mounjaro , Walmart , Eli-lilly , Novo-nordisk , Multiple-endocrine-neoplasia , Zepbound , Da , Li-lilly , Lp-1

1st study finds surge of weight loss drugs in health system

A new study of 87,935 patients in California reveals an

United-states , California , Irvine , University-of-california , University-of-california-health , California-health , Only-saxenda , Wegovy , Ounjaro , Dlyxin , Yetta

Costly weight-loss drugs are draining the NC State Health Plan. Can coverage continue?

“We’re on a trajectory of the health plan being financially under siege because of this one product,” said State Treasurer Dale Folwell.

Connecticut , United-states , Michigan , North-carolina , Raleigh , Kajal-zalavadia , Andrea-coviello , Dale-folwell , Nc-state-health-plan , Health-plan , School-of-medicine-weight-management-program , Carolina-state-health-plan

Study links Ozempic with stomach paralysis

A study published in JAMA found that the active ingredients of Ozempic, Wegovy and Saxenda are associated with an increased risk of stomach paralysis.

Canada , Novo-nordisk , Ozempic , Egovy , Axenda , Tomach-paralysis , Ama , Ype-2-diabetes , Eight-loss , Ontrave , Astroparesis

More than 9M Ozempic, GLP-1 prescriptions written in Q4 2022

In the last three months of 2022, physicians prescribed more than 9 million doses of obesity drug Saxenda and two diabetes medications, Ozempic and Mounjaro.

Trilliant-health , Obesity , Axenda , Zempic , Ounjaro , Lp-1 , Iabetes , Eight-loss , Ype-2-diabetes , Ovo-nordisk , Li-lilly

High demand drives Irish shortage of weight-loss drug Saxenda

The regulator warned that the shortage of the obesity medicine, recently added to the drug payment scheme, will continue until next month.

Ireland , Francis-finucane , Jack-shanahan , Co-kerry , Department-of-health , European-medicine-agency , Galway-university-hospital , Novo-nordisk , Health-products-regulatory-authority , Medical-council , Irish-saxenda , Hpra

Regulators are investigating claims of suicidal thoughts and self-harm in Ozempic and Wegovy patients

European regulators are looking into about 150 reports of self-harm and suicidal thoughts in patients taking GLP-1 drugs including Ozempic and Wegovy.

Michigan , United-states , Amy-rothberg , European-union , European-medicines-agency , University-of-michigan , Drug-administration , Novo-nordisk , Suicidal-thoughts , Uicidal-behaviors , Iabetes-drugs , Eight-loss

Live Breaking News & Updates on Axenda

A new study of 87,935 patients in California reveals an United-states , California , Irvine , University-of-california , University-of-california-health , California-health , Only-saxenda , Wegovy , Ounjaro , Dlyxin , Yetta

A study published in JAMA found that the active ingredients of Ozempic, Wegovy and Saxenda are associated with an increased risk of stomach paralysis.Canada , Novo-nordisk , Ozempic , Egovy , Axenda , Tomach-paralysis , Ama , Ype-2-diabetes , Eight-loss , Ontrave , Astroparesis

In the last three months of 2022, physicians prescribed more than 9 million doses of obesity drug Saxenda and two diabetes medications, Ozempic and Mounjaro.Trilliant-health , Obesity , Axenda , Zempic , Ounjaro , Lp-1 , Iabetes , Eight-loss , Ype-2-diabetes , Ovo-nordisk , Li-lilly

A new study of 87,935 patients in California reveals an

United-states , California , Irvine , University-of-california , University-of-california-health , California-health , Only-saxenda , Wegovy , Ounjaro , Dlyxin , Yetta

A study published in JAMA found that the active ingredients of Ozempic, Wegovy and Saxenda are associated with an increased risk of stomach paralysis.

Canada , Novo-nordisk , Ozempic , Egovy , Axenda , Tomach-paralysis , Ama , Ype-2-diabetes , Eight-loss , Ontrave , Astroparesis

In the last three months of 2022, physicians prescribed more than 9 million doses of obesity drug Saxenda and two diabetes medications, Ozempic and Mounjaro.

Trilliant-health , Obesity , Axenda , Zempic , Ounjaro , Lp-1 , Iabetes , Eight-loss , Ype-2-diabetes , Ovo-nordisk , Li-lilly